US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beta Bionics, Inc.

10.05

-1.0900-9.78%

Post-market: 10.050.00000.00%16:05 EDT

Volume:291.91K

Turnover:2.99M

Market Cap:435.66M

PE:-1.17

High:11.06

Open:11.06

Low:10.04

Close:11.14

Loading ...

Overview Company News Filings

Beta Bionics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $28

THOMSON REUTERS

Beta Bionics Initiated at Outperform by Leerink Partners

Stifel Initiates Beta Bionics at Buy With $25 Price Target

MT Newswires Live

Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target

MT Newswires Live

Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target

MT Newswires Live

Beta Bionics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Beta Bionics, Inc. (BBNX)

Beta Bionics initiated with an Overweight at Piper Sandler

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target

MT Newswires Live

Beta Bionics initiated with a Neutral at Baird

Major Shareholder Makes Bold Move with Huge Stock Purchase

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oil company Infinity Natural Resources debuts IPO amid deregulation push

Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand

Beta Bionics Shares Rise in Nasdaq Debut

MT Newswires Live

BRIEF-Beta Bionics Priced IPO At $17.00 Per Share

Beta Bionics raises $204 mln in upsized US IPO

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BBNX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":10.05,"timestamp":1745265600000,"preClose":11.14,"halted":0,"volume":291905,"hourTrading":{"tag":"盘后","latestPrice":10.05,"preClose":10.05,"latestTime":"16:05 EDT","volume":288,"amount":2894.4,"timestamp":1745265911740},"delay":0,"floatShares":35572413,"shares":43348840,"eps":-8.602584,"marketStatus":"Not Yet Opened","change":-1.09,"latestTime":"04-21 16:00:00 EDT","open":11.06,"high":11.06,"low":10.04,"amount":2991806.0912,"amplitude":0.091562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.602584,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":11.14,"preHourTrading":{"tag":"盘前","latestPrice":10.9,"preClose":11.14,"latestTime":"08:37 EDT","volume":10,"amount":109,"timestamp":1745239047301},"postHourTrading":{"tag":"盘后","latestPrice":10.05,"preClose":10.05,"latestTime":"16:05 EDT","volume":288,"amount":2894.4,"timestamp":1745265911740},"volumeRatio":0.858342},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":35572413,"roa":"-21.78%","roe":"-81.35%","lyrEps":-8.602584,"volumeRatio":0.858342,"shares":43348840,"dividePrice":0,"high":11.06,"amplitude":0.091562,"preClose":11.14,"low":10.04,"week52Low":8.89,"pbRate":"-1.78","psRate":"6.69","week52High":24.5,"institutionHeld":0,"latestPrice":10.05,"eps":-8.602584,"divideRate":0,"volume":291905,"delay":0,"ttmEps":-8.602584,"open":11.06,"prevYearClose":17,"prevWeekClose":11.14,"prevMonthClose":12.24,"prevQuarterClose":12.24,"fiveDayClose":10.91,"twentyDayClose":15.1,"sixtyDayClose":17,"earningDate":1746460800000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513723314","title":"Beta Bionics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723314?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:28","pubTimestamp":1740400085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513672371","title":"Beta Bionics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2513672371","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513672371?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:23","pubTimestamp":1740399780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 07:23 ET (12:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2513284237","title":"Stifel Initiates Beta Bionics at Buy With $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513284237","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513284237?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:14","pubTimestamp":1740399295,"startTime":"0","endTime":"0","summary":"Stifel Initiates Beta Bionics at Buy With $25 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","BBNX"],"gpt_icon":0},{"id":"2513426728","title":"Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513426728","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513426728?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:14","pubTimestamp":1740399286,"startTime":"0","endTime":"0","summary":"Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2513472892","title":"Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472892","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513472892?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:10","pubTimestamp":1740399023,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2513074905","title":"Beta Bionics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2513074905","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513074905?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:00","pubTimestamp":1740394858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513741347","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513741347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513741347?lang=en_us&edition=fundamental","pubTime":"2025-02-24 18:50","pubTimestamp":1740394210,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GE Healthcare Technologies Inc (GEHC – Research Repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","LU0354030438.USD","LU0943347566.SGD","LU0124676726.USD","BK4501","LU0868494617.USD","BK4585","LU0820561818.USD","LU0689626769.HKD","LU1280957306.USD","LU0820562030.AUD","LU0640476718.USD","LU1988902786.USD","LU0689472784.USD","LU0354030511.USD","BK4082","GE","LU2756315664.SGD","BK4543","LU1551013342.USD","LU1366333091.USD","LU1064131342.USD","BK4588","LU2756315318.SGD","LU0149725797.USD","BK4187","GEHC","BK4206","BBNX","LU1261432733.SGD","LU1551013425.SGD","LU1093756325.SGD","LU0820561909.HKD","LU2264538146.SGD","LU0157215616.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2513749333","title":"Beta Bionics initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2513749333","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513749333?lang=en_us&edition=fundamental","pubTime":"2025-02-24 18:17","pubTimestamp":1740392264,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Matt O’Brien initiated coverage of Beta Bionics (BBNX) with an Overweight rating and $26 price target The company has a “uniq...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2513072295","title":"Palantir initiated, Roku upgraded: Wall Street’s top analyst calls","url":"https://stock-news.laohu8.com/highlight/detail?id=2513072295","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513072295?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:35","pubTimestamp":1740148520,"startTime":"0","endTime":"0","summary":"The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly.Discover the Best Stocks and Maximize Your Portfolio:. See what stocks are receiving strong buy ratings from top-rated analysts.Filter, analyze, and streamline your search for investment opportunities with  TipRanks’ Stock Screener.Jefferies upgraded Roku  to Hold from Underperform with a price target of $100, up from $55, following the Q4 outperformance. Roku’s 25% year-over-year Platform growth was well ahead of its guidance as the company executes on third party integrations and improving fill rates, the firm tells investors in a research note.Morgan Stanley upgraded SolarEdge  to Equal Weight from Underweight with a price target of $18, up from $11. The company’s stronger free cash flow generation and clearer strategic direction reduces liquidity concerns, the firm tells investors in a research note.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/palantir-initiated-roku-upgraded-wall-143520208.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palantir-initiated-roku-upgraded-wall-143520208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GRAB","NXPI","BBNX","ZSPC","SEDG","AXON","GRABW","PVLA","ROKU","DTE","CMS","CE","LRCX","PLTR","BAX","SNOW"],"gpt_icon":1},{"id":"2512441927","title":"Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2512441927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512441927?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:37","pubTimestamp":1740055078,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2512432838","title":"Beta Bionics initiated with a Neutral at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2512432838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512432838?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:16","pubTimestamp":1739999776,"startTime":"0","endTime":"0","summary":"Baird initiated coverage of Beta Bionics (BBNX) with a Neutral rating and $20 price target Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-neutral-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-neutral-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2508473105","title":"Major Shareholder Makes Bold Move with Huge Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2508473105","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508473105?lang=en_us&edition=fundamental","pubTime":"2025-02-04 10:02","pubTimestamp":1738634526,"startTime":"0","endTime":"0","summary":"New insider activity at Beta Bionics, Inc. ( ($BBNX) ) has taken place on February 4, 2025. In a noteworthy transaction, significant shareholder We...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-shareholder-makes-bold-move-with-huge-stock-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-shareholder-makes-bold-move-with-huge-stock-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2508137915","title":"Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2508137915","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508137915?lang=en_us&edition=fundamental","pubTime":"2025-02-01 06:56","pubTimestamp":1738364160,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan.  31, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/31/3019047/0/en/Beta-Bionics-Announces-Closing-of-234-6-Million-Initial-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2507961888","title":"Oil company Infinity Natural Resources debuts IPO amid deregulation push","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507961888?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:20","pubTimestamp":1738336800,"startTime":"0","endTime":"0","summary":"Company prices above midrange as the largest of a batch of initial public offerings on Friday. Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong stock-market debut for the oil and gas producer, which operates in Ohio and Pennsylvania.The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the \"drill, baby, drill\" slogan in his inaugural address.Earlier this week, Sean Duffy, the newly sworn-in Transportation secretary, ordered a review of fuel-economy standards laid out by the Biden administration.Infinity Natural Resources  priced 13.25 million shares at $20 for proceeds of $265 million. The IPO priced toward the upper end of its range of $18 to $21 in a sign of healthy demand.Infinity Natural Resources is the largest of a handful of IPOs on Friday.Maze Therapeutics Inc.  priced 8.75 million shares at $16 a share for proceeds of $140 million. The stock priced at the midpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","BBNX","MAZE","INR"],"gpt_icon":0},{"id":"1108410193","title":"Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1108410193","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108410193?lang=en_us&edition=fundamental","pubTime":"2025-01-31 01:38","pubTimestamp":1738258708,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering  on the Nasdaq stock exchange.The biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO lev","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2507676187","title":"Beta Bionics Shares Rise in Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2507676187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507676187?lang=en_us&edition=fundamental","pubTime":"2025-01-31 01:34","pubTimestamp":1738258497,"startTime":"0","endTime":"0","summary":"Beta Bionics  shares debuted on Nasdaq Thursday with an opening price of $22, above the initial public offering price of $17.Shares were recently changing hands at $23.28 apiece, up almost 37% from the IPO price.The stock debuted on the Nasdaq Global Market under the \"BBNX\" ticker.The IPO consisted of 12 million shares and the company granted underwriters an option to buy up to an additional 1.8 million shares consisting of 475,000 shares from Beta Bionics and over 1.3 million shares from existing stockholders.The company said it expects to generate $204 million from the IPO before the overallotment option is exercised.Price: 23.28, Change: +6.28, Percent Change: +36.91","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2095319765.USD","LU2210149790.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210150020.SGD",".IXIC","BK4585","NQmain","BK4588","BBNX"],"gpt_icon":0},{"id":"2507069273","title":"BRIEF-Beta Bionics Priced IPO At $17.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2507069273","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507069273?lang=en_us&edition=fundamental","pubTime":"2025-01-30 12:07","pubTimestamp":1738210051,"startTime":"0","endTime":"0","summary":"BRIEF-Beta Bionics Priced IPO At $17.00 Per ShareJan 29 (Reuters) - BETA BIONICS ANNOUNCES PRICING OF UPSIZED $204 MILLION INITIAL PUBLIC OFFERINGBETA BIONICS - IPO PRICED AT $17.00 PER SHARESource text: ID:nGNX8pQnrNFurther company coverage: BBNX.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OP1RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2507692758","title":"Beta Bionics raises $204 mln in upsized US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2507692758","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507692758?lang=en_us&edition=fundamental","pubTime":"2025-01-30 12:07","pubTimestamp":1738210036,"startTime":"0","endTime":"0","summary":"Jan 29  - Insulin delivery device maker Beta Bionics said on Wednesday it raised $204 million in its initial public offering  at a valuation of about $700 million.The U.S.-based company said it priced its IPO at $17 per share, the upper-end of its forecasted range of $16 to $17 per share.The size of the offering was raised to 12 million shares from 10 million shares, the company said.Beta bucks the recent trend where major IPO candidates such as LNG exporter Venture Global VG.N and pork producer Smithfield Foods SFD.O had to lower their valuation targets.Beta's shares will start trading on the Nasdaq under the symbol \"BBNX\" on Thursday.BofA Securities, Piper Sandler, Leerink Partners, Stifel and Lake Street are the underwriters for the offering.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nL3N3OQ07F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","LU1496350171.SGD","LU1668664300.SGD","00288","LU1880398471.USD","LU1162221912.USD","LU0683600562.USD","IE00B19Z3B42.SGD","LU2129689605.HKD","LU1201861249.SGD","LU1363072403.SGD","LU0980610538.SGD","LU0052756011.USD","SGXZ90724238.SGD","VG","LU0321505868.SGD","SIVBQ","BK4585","BBNX","LU1883839398.USD","BK4588","IE00BLSP4239.USD","LU2129689514.USD","LU1718418525.SGD","LU0274383008.USD","BK4553","LU2133065610.SGD","LU0130102774.USD","BK1603","LU0130103400.USD","SG9999001226.SGD","LU1280957306.USD","SG9999001051.SGD","BAC","BK4211","IE00BKVL7J92.USD","LU0256863811.USD","SF","LU1166156734.SGD","LU1496350502.SGD","SG9999002950.SGD","IE00BBT3K403.USD","BK4127","BK1237","LU0287142896.SGD","LU0320765646.SGD","LU0170899867.USD","LU0321505439.SGD","PIPR","SFD"],"gpt_icon":0},{"id":"2507019694","title":"Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2507019694","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507019694?lang=en_us&edition=fundamental","pubTime":"2025-01-30 11:34","pubTimestamp":1738208040,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan.  29, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized ini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/30/3017688/0/en/Beta-Bionics-Announces-Pricing-of-Upsized-204-Million-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2025-05-06","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"defaultRemindTime":1746561600000,"name":null,"time":"Post Market","dateTimestamp":1746504000000,"actualEps":null},{"market":"US","date":"2025-03-25","symbol":"BBNX","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5714,"buy":0.2857,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1740628800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2025-04-17","current":-8.660901,"percent":0.836364,"low":-18.401318,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"high":-3.90273,"avg":-12.94413,"sd":3.640723,"marketCap":474236309},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309}],"updateTime":1745276975375}}}